Vulnerable research participants: anyone may qualify.

Area of Science:

• Bioethics
• Clinical Research Ethics
• Regulatory Science

Background:

• Federal regulations provide guidelines for research involving traditionally identified vulnerable populations.
• Emergent illness, end-of-life situations, or impaired capacity can render individuals vulnerable, irrespective of prior identification.
• Current healthcare demands necessitate a broader understanding of vulnerability in research.

Purpose of the Study:

• To provide an overview of institutional review board (IRB) functions related to participant protection.
• To outline IRB roles, responsibilities, and processes for assessing vulnerability and capacity to consent.
• To offer suggestions for IRBs to address the evolving needs of vulnerable research participants.

Main Methods:

• Review of existing federal regulations and ethical guidelines.
• Analysis of the concept of vulnerability beyond traditional definitions.
• Discussion of institutional review board processes for capacity assessment.

Main Results:

• IRBs must consider a dynamic range of factors when assessing participant vulnerability.
• Capacity to consent can be transient and influenced by acute health conditions or end-of-life circumstances.
• Proactive and adaptive IRB strategies are crucial for safeguarding participants in complex situations.

Conclusions:

• IRBs play a critical role in protecting participants who may not fit traditional vulnerability criteria.
• Assessment of vulnerability and capacity to consent requires a nuanced, context-specific approach.
• Adapting IRB practices is essential to align with contemporary healthcare realities and protect all research participants effectively.